New executive leadership appointments
As an Everyone Included™ organization, Medicine X believes in the importance of diverse talent, experience and perspective as drivers of innovation in health care. Last year we issued a call for leaders from the Medicine X community and the response was overwhelming. We received over 250 completed applications for leadership positions within our organization.
We are truly humbled by the diverse talent and expertise represented by the Medicine X global community. Our leadership is still working through all nominations for advisory panels for 2016. We anticipate the announcement of advisory panel chairs and members within the next few weeks.
However, we are pleased to mark the start of the new year by announcing some new senior leadership appointments to our program executive board.
Ruchin Kansal, MBA, Pamela Ressler, RN and Michael Seres join Medicine X Program Executive Board
Medicine X is pleased to announce three new members have been elected to the Medicine X program executive board. Please help us welcome Ruchin Kansal, MBA, Pamela Ressler, RN and Michael Seres as the newest members of our program executive board. Ruchin, Pamela and Michael will each serve two-year terms ending December 31, 2017. The terms for the remaining members of the current program executive board end December 31, 2016. Nominations for these positions will open in late summer. Our Medicine X program executive board represents our senior leadership council and guides global efforts relating to all program development at Medicine X.
About Ruchin Kansal, MBA:
Ruchin Kansal has global experience as an executive, strategic advisor and an entrepreneur in the biopharmaceutical and medical devices industry. Trained as an architect, he brings design thinking to the world of business. He is adept at launching and maturing new businesses and capabilities–and driving large scale transformation programs.
Ruchin currently serves as the head of business innovation at Boehringer Ingelheim Pharmaceuticals, Inc. He is responsible for incubating the development and evolution of strategic capabilities that adapt Boehringer Ingelheim’s business to a changing market environment.
Prior to Boehringer Ingelheim, Mr. Kansal worked at Deloitte Consulting and Cap Gemini Ernst & Young . He holds an undergraduate degree in Architecture from the Indian Institute of Technology (IIT), Roorkee, Masters in Architecture from Kansas State University, and MBA from NYU-Stern.
About Pamela Ressler, RN: Pamela Katz Ressler, RN, MS, HN-BC is the founder of Stress Resources in Concord, Massachusetts, a firm specializing in building resiliency for individuals and organizations through tools of connection, communication and compassion. Pam is a frequent, sought after speaker to local, national and international audiences on strategies of resilience. She is a faculty member at Tufts University School of Medicine in the Pain Research, Education and Policy Program and is an appointed member of the Consumer Health Advisory Board of the Massachusetts Health Quality Partners.
About Michael Seres: A healthcare social media speaker, adviser, and author born in London, Michael was diagnosed at 12 with Crohn’s Disease. He studied law & politics at LSE before surgery interrupted his studies. After 20 operations and intestinal failure, Michael underwent a rare small bowel transplant in the UK. Prior to transplant, Michael started blogging. His blog is now the official patient blog of the Intestinal Transplant Association. Michael serves on the executive committee of Oxford Transplant Foundation. He is the patient spokesperson for national quality food standards in NHS hospitals. Michael builds online patient communities through social media and launched the #IBDChat. He’s founder of connected medical device company 11Health, runs the patient strand of NHSSM, is a patient scholar at Stanford Medicine X and a UK Ambassador for Doctors 2.0 & You!
Nick Dawson, MHA appointed to Chair-Elect of Program Executive Board
We are also pleased to announce that Nick Dawson has been selected to serve as the inaugural chair-elect of the program executive board in 2016. Nick will assume responsibilities for leading the program executive board in its Everyone Included co-creation and leadership model as chair in 2017-18. As the Executive Director of Medicine X I will mentor Nick as chair-elect this year and serve as Emeritus chair and ex-officio member of the program executive board in 2017.
About Nick Dawson, MHA: In 2014 Nick joined Johns Hopkins as Executive Director of the Sibley Innovation Hub. In the Innovation Hub he helps lead a human-centered design team to tackle both simple and complex challenges for patients, staff and providers. His past roles include hospital leadership of departments including strategy, finance and operations.